Page 96 - Haematologica Vol. 109 - July 2024

ARTICLE - Targeting TNF/IL-17/MAPK in hE2A-PBX1 zebrafish
H. Luo et al.
42. Yan Z, Dai J, Wang J, et al. RNF167-mediated ubiquitination of Tollip inhibits TNF-α-triggered NF-κB and MAPK activation. FASEB J. 2023;37(8):e23089.
43. Niu L, Fang Y, Yao X, et al. TNFα activates MAPK and Jak-Stat pathways to promote mouse Muller cell proliferation. Exp Eye Res. 2021;202:108353.
44. Sabio G, Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol. 2014;26(3):237-245.
45. Aslani MR, Sharghi A, Boskabady MH, et al. Altered gene expression levels of IL-17/TRAF6/MAPK/USP25 axis and pro- inflammatory cytokine levels in lung tissue of obese ovalbumin- sensitized rats. Life Sci. 2022;296:120425.
46. Roussel L, Houle F, Chan C, et al. IL-17 Promotes p38 MAPK- dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol. 2010;184(8):4531-4537.
47. Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002;282(6):G1035-G1044.
48. Sloan SR, Shen CP, McCarrick-Walmsley R, Kadesch T. Phosphorylation of E47 as a potential determinant of B-cell- specific activity. Mol Cell Biol. 1996;16(12):6900-6908.
49. Licht JD. Oncogenesis by E2A-PBX1 in ALL: RUNX and more. Blood. 2020;136(1):3-4.
50. Huang A, Zhao H, Quan Y, Jin R, Feng B, Zheng M. E2A Predicts prognosis of colorectal cancer patients and regulates cancer cell growth by targeting miR-320a. Plos One. 2014;9(1):e85201.
51. Xu W, Carr T, Ramirez K, McGregor S, Sigvardsson M, Kee BL.
E2A transcription factors limit expression of Gata3 to facilitate
T lymphocyte lineage commitment. Blood. 2013;121(9):1534-1542. 52. Lu Q, Kamps MP. Selective repression of transcriptional
activators by Pbx1 does not require the homeodomain. Proc Natl
Acad Sci U S A. 1996;93(1):470-474.
53. Mandal JP, Shiue C-N, Chen Y-C, et al. PKCδ mediates
mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression. Free Radic Biol Med. 2021;163:69-87.
54. Tian Y, Korn P, Tripathi P, et al. The mono-ADP-ribosyltransferase ARTD10 regulates the voltage-gated ion channel Kv1.1 through protein kinase C delta. BMC Biol. 2020;18(1):143.
55. Murthy S, Desantis J, Verheugd P, et al. 4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10. Eur J Med Chem. 2018;156:93-102.
56. Hart JR, Garner AL, Yu J, et al. Inhibitor of MYC identified in a Krohnke pyridine library. Proc Natl Acad Sci U S A. 2014;111(34):12556-12561.
57. Lourenco C, Resetca D, Redel C, et al. MYC protein interactors in gene transcription and cancer. Nat Rev Cancer. 2021;21(9):579-591.
58. Windmoeller BA, Beshay M, Helweg LP, et al. Novel primary human cancer stem-like cell populations from non-small cell lung cancer: inhibition of cell survival by targeting NF-κB and MYC signaling. Cells. 2021;10(5):1024.
59. Hong L, Kenney SR, Phillips GK, et al. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem. 2013;288(12):8531-8543.
Haematologica | 109 July 2024
2110